Get the Stockscreener App
0.63
22.57%
0.116
After Hours:
.71
0.08
+12.70%
Adial Pharmaceuticals Inc stock is traded at $0.63, with a volume of 25.34M.
It is up +22.57% in the last 24 hours and up +88.00% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$0.514
Open:
$0.6
24h Volume:
25.34M
Relative Volume:
3.12
Market Cap:
$6.57M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.109
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
+24.26%
1M Performance:
+88.00%
6M Performance:
-24.10%
1Y Performance:
-40.00%
1-Day Range:
$0.5609
$0.689
1-Week Range:
$0.3513
$0.689
52-Week Range:
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.63 | 8.11M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Adial Pharmaceuticals Skyrockets 28.09% – What’s Fueling This Volcanic Surge? - AInvest
What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakthrough stock performance - jammulinksnews.com
What catalysts could drive Adial Pharmaceuticals Inc. stock higher in 2025Capitalize on strong market momentum - jammulinksnews.com
What are analysts’ price targets for Adial Pharmaceuticals Inc. in the next 12 monthsFind market-beating stocks for your portfolio - jammulinksnews.com
Is it the right time to buy Adial Pharmaceuticals Inc. stockHarness the power of proven investment plans - jammulinksnews.com
Adial Pharmaceuticals Inc. (ADIL) Soars 16.73% on Promising Clinical Trial Results - AInvest
Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025Unlock daily market insights for better decisions - jammulinksnews.com
Does Adial Pharmaceuticals Inc. stock perform well during market downturnsHigh-octane financial growth - jammulinksnews.com
What are the latest earnings results for Adial Pharmaceuticals Inc.Discover the next big stock winners - jammulinksnews.com
What drives Adial Pharmaceuticals Inc. stock priceSky-high profits - PrintWeekIndia
Adial Pharmaceuticals Inc. Stock Analysis and ForecastHigh-profit trading signals - PrintWeekIndia
Why Adial Pharmaceuticals Inc. stock is on top investor watchlistsAccelerated capital growth - jammulinksnews.com
Is Adial Pharmaceuticals Inc. a good long term investmentHigh-yield portfolio picks - PrintWeekIndia
What analysts say about Adial Pharmaceuticals Inc. stockExtraordinary profit generation - PrintWeekIndia
Published on: 2025-07-24 22:20:15 - jammulinksnews.com
Autolus Therapeutics Soars 10.79% on EU Approval of AUCATZYL - AInvest
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):